Online citations, reference lists, and bibliographies.
← Back to Search

MICROSPHERES AS AN OCULAR DRUG DELIVERY SYSTEM- A REVIEW

Tejpal Yadav
Published 2013 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Ophthalmic drug delivery is most interesting and challenging delivery system facing the pharmaceutical scientist. The anatomy, physiology, and biochemistry of the eye render this organ highly impervious to foreign substances. A significant challenge to the formulator is to circumvent the protective barriers of the eye without causing permanent tissue damage. These barriers affect the bioavailability of drugs. Development of newer, more sensitive diagnostic techniques and novel therapeutic agents continue to provide ocular delivery systems with high therapeutic efficacy. These includes iontophoresis, liposome bioadhesive gels, ocular insert, contact lenses, liposomes & a special one is microspheres. Microsphere is a well designed controlled drug delivery system can overcome some of the problems of conventional therapy and enhance the therapeutic efficacy of a given drug. This approach delivering a therapeutic substance to the target site in a sustained controlled release fashion & achive a good bioavalability in ocular delivery system.
This paper references
Piloplex 3.4) A long acting anti-glaucoma medication
Z Mazor (1984)
Preliminary study of prolonged acting drug delivery system for the treatment of glaucoma.
R. Gurny (1981)
10.1136/bjo.63.1.45
Piloplex, a new long-acting pilocarpine polymer salt. A: Long-term study.
U. Ticho (1979)
10.1016/0378-5173(90)90248-3
Antiglaucomatous activity of betaxolol chlorhydrate sorbed onto different isobutylcyanoacrylate nanoparticle preparations
L. Marchal-Heussler (1990)
The kinetics of in vitro release and the pharamcokinetics of miotie response in rabbits of gelatin and albumin microspheres
SE Leucuta (1989)
10.1016/S0378-5173(01)00760-8
Chitosan nanoparticles: a new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to cyclosporin A.
A. M. de Campos (2001)
New ophthalmic drug release systems: formulation and ocular disposition of amikacin-loaded nanoparticles, 5th Int
M J Alonso (1989)
Effect of betamethasone phosphate–loaded polyactide nanoparticles on experimental autoimmune uveoretinitis
T. Sakai (2004)
Evaluation of pilocarpine-loaded albumin particles as drug delivery systems for controlled delivery in the eye II
A K Zimmer (1995)
10.1089/JOP.2007.0002
Inhibitory efficacy of intravitreal dexamethasone acetate-loaded PLGA nanoparticles on choroidal neovascularization in a laser-induced rat model.
Jianfeng Xu (2007)
Effet tensionnel après instillation d'une goutte de pilocarpine retard. Résultats cliniques de son action à moyen terme.
C. Andermann (1983)
10.3109/02652048609049580
A solid colloidal drug delivery system for the eye: encapsulation of pilocarpin in nanoparticles.
T. Harmia (1986)
10.1016/0168-3659(87)90090-3
Design and evaluation of controlled release systems for the eye
R. Gurny (1987)
10.3109/02652048509033840
The in vivo evaluation of poly(lactic acid) microcapsules of pilocarpine hydrochloride.
V. Vidmar (1985)
A doseresponse study of piloplex for duration of action in humans
HZ Klein (1985)
New ophthalmic drug release systems: formulation and ocular disposition of amikacin-loaded nanoparticles
MJ Alonso (1989)
Polycaprolaction colloidal carriers for controlled ophthalmic delivery
P Maincent (1992)
Comp . study of the visual effects of pilocarpine and piloplex eye drops
Z Mazor (1979)
Nanocapsules de P-bloquants, un nouveau vecteur de mkdicaments en ophthalmologie
L Marchal-Heussler (1991)
10.1016/J.JCONREL.2004.05.016
Starch acetate microparticles for drug delivery into retinal pigment epithelium-in vitro study.
L. Tuovinen (2004)
MICROSPHERES AS A NOVEL DRUG DELIVERY SYSYTEM-A REVIEW
Alagusundaram (2009)
The use of polyphthalamide microcapsules for obtaining extended periods of therapy in the eye
M Beal
Rakesh Kumar Jat, Vice principal, Rajasthan pharmacy college
Professor
DESIGN AND CHARACTERIZATION OF BIOADHESIVE IN-SITU GELLING OCULAR INSERTS OF GATIFLOXACIN SESQUIHYDRATE
D. Mishra (2008)
Nanoparticles. In Colloidal Drug Delivery
J. Kreuter (1994)
Design and characterization of bioadhesive in-situ gelling ocular insert of gatifloxacin sesquihydrate
DN Mishra (2008)
The preparation and properties of polyamide microcapsules containing pilocarpine in solutions
ME Evans (1981)
Glaubid (Piloplex 3.4) A long acting anti-glaucoma medication
Z Mazor (1984)
10.1016/S0378-5173(00)00508-1
Ketorolac entrapped in polymeric micelles: preparation, characterisation and ocular anti-inflammatory studies.
A. Gupta (2000)
one-month crossover trial comparing the safety and intraocular pressure control in patients treated with piloplex 3.4 applied twice dialy with those treated with pilocarpine 2% applied 4 times daily
E Duzman (1983)
Colloidal drug delivery systems for the eye: A comparison of the efficacy of three different polymers: Polyisobutylcyanoacrylate, polylactic-co-glycolic acid, polyepsilon- caprolacton
L Marchal-Heussler (1992)
Ophthalmic drug delivery : biopharmaceutical, technological and clinical aspects
M. Saettone (1987)
Piloplex, a new longacting pilocarpine polymer salt B: Comp. study of the visual effects of pilocarpine and piloplex eye
Z Mazor (1979)
OCULAR DRUG DELIVERY SYSTEM: AN OVERVIEW
M. K. Sikandar (2011)
10.1016/J.EJPB.2003.10.018
PLGA microspheres for the ocular delivery of a peptide drug, vancomycin using emulsification/spray-drying as the preparation method: in vitro/in vivo studies.
E. Gavini (2004)
10.1080/10611860290022660
Efficacy of Ganciclovir-loaded Nanoparticles in Human Cytomegalovirus (HCMV)-infected Cells
M. Merodio (2002)
VHK, Ocular disposition and bioavailability of pilocarpine from piloplex and other sustained release drug delivery
Robinson (1984)
10.1016/j.nano.2008.06.003
Ocular nanoparticle toxicity and transfection of the retina and retinal pigment epithelium.
Tarl W. Prow (2008)
Ophthalmological bioerodible drug dispensing formulation , U . S . Patent 4 , 001 ,
JW Shell (1992)
DJG, The use of polyphthalamide microcapsules for obtaining extended periods of therapy in the eye. In: Davis, Illurn, McVie, Tomlinson (Eds.) Microspheres and Drug Therapy
M Beal (1984)
Pilocarpin Augentropfen mit einem neuartigen Pilocarpin- Polymersalz
R Stodtmeister (1979)
a new long - acting pilocarpine polymer salt : A : Long - term study
U Ticho (1979)
Microspheres: a review, World journal of pharmacy and pharmaceutical sciences
S Khan (2012)
Further clinical trial with piloplex: A new long acting pilocarpine salt, Glaucoma
M Blumenthal (1979)
10.1167/IOVS.02-1068
Ocular drug delivery targeting the retina and retinal pigment epithelium using polylactide nanoparticles.
Jean-Louis Bourges (2003)
Ophthalmological bioerodible drug dispensing formulation
J W Shell (1977)
10.1016/j.exer.2008.04.002
Hyaluronic acid coated poly-epsilon-caprolactone nanospheres deliver high concentrations of cyclosporine A into the cornea.
I. Yenice (2008)
VHK , Ocular disposition and bioavailability of pilocarpine from piloplex and other sustained release drug delivery systems , in : Ticho U . and David R . ( Eds . ) , Recent Advances in Glaucoma
Robinson (1984)
10.1201/b19309
Encyclopedia of Pharmaceutical Technology
J. Swarbrick (2006)
10.1007/BF02169795
Comparison of different models for the testing of pilocarpine eyedrops using conventional eyedrops and a novel depot formulation (nanoparticles)
R. Diepold (2005)
10.1016/0378-5173(94)90243-7
Hydrocortisone delivery to healthy and inflamed eyes using a micellar polysorbate 80 solution or albumin nanoparticles
A. Zimmer (1994)
Nanoencapsulation of timolol by suspension and micelle polymerization
T Harmia-Pulkkinen (1986)
Entwicklung und Untersuchung von kolloidalen Depot-Arzneistofftrtigersystemen zur Glaukombehandlung, Dissertation, Fachbereich Biochemie, Pharmazie und Lebensmittelchemie, JWG-Universitst
RW Diepold (1988)
Etude comparative de I’activid antiglaucomateuse de glauplex 2 et du nitrate de pilocarpine sur le glaucome experimental a l’alphachymotrypsine
C Andermann (1982)
Boylan (Eds.), Encyclopedia of Pharmaceutical Technology
J Kreuter (1994)
10.1002/1520-6017(200103)90:3<288::AID-JPS4>3.0.CO;2-5
Ocular tolerability and in vivo bioavailability of poly(ethylene glycol) (PEG)-coated polyethyl-2-cyanoacrylate nanosphere-encapsulated acyclovir.
M. Fresta (2001)
10.1111/j.2042-7158.1981.tb11678.x
THE PREPARATION AND PROPERTIES OF POLYAMIDE MICROCAPSULES CONTAINING PILOCARPINE IN SOLUTION
M. E. Evans (1981)
A NEW TREND : OCULAR DRUG DELIVERY SYSTEM
Jitendra (2011)
10.3109/02652048609031575
Ocular drug delivery of progesterone using nanoparticles.
V. Li (1986)
A and Mazor Z, A new long-acting pilocarpine compound
U Ticho (1978)
Effet tensionnel apres instillation dune goutte de pilocarpine retard
C Andermann (1983)
Evaluation of nanoparticles as drug delivery systems , Preparation methods
J Kreuter (1983)
Ocular drug delivery systems. In novel drug delivery
YW Chien (1996)
Tolerance studies and pharrnacokinetic evaluation of indomethacin - loaded nanocapsules in rabbit eyes
P Billardon (1994)
10.1016/J.EJPHAR.2005.02.019
Subconjunctivally administered celecoxib-PLGA microparticles sustain retinal drug levels and alleviate diabetes-induced oxidative stress in a rat model.
S. Ayalasomayajula (2005)
Further clinical trial with piloplex : A new long acting pilocarpine salt
M Blumenthal (1979)
Developpement et Cvaluation d'un noveau type de forme ophthalmique g IibCration prolong&e, 2ttme Congrtts Europten de
T Boye (1984)
10.1007/s12272-001-1266-6
Chitosan based nanocarriers for indomethacin ocular delivery
A. Badawi (2008)
10.1136/bjo.63.1.48
Piloplex, a new long-acting pilocarpine polymer salt. B: Comparative study of the visual effects of pilocarpine and Piloplex eye drops.
Z. Mazor (1979)
10.1016/J.CARBPOL.2007.11.007
Chitosan nanoparticles loaded with dorzolamide and pramipexole
Sofia A. Papadimitriou (2008)
Developpement et Cvaluation d’un noveau type de forme ophthalmique g IibCration prolong&e
T Boye (1984)
COMPARATIVE REVIEW ON CONVENTIONAL AND ADVANCED OCULAR DRUG DELIVERY FORMULATIONS
Karan Arul (2010)
A new long - acting pilocarpine compound
U Ticho (1978)
10.1016/0169-409X(95)00017-2
Microspheres and nanoparticles used in ocular delivery systems
A. Zimmer (1995)
10.1016/0168-3659(94)90225-9
Evaluation of pilocarpine-loaded albumin particles as drug delivery systems for controlled delivery in the eye. I: In vitro and in vivo characterisation
A. Zimmer (1994)
10.1016/0378-5173(86)90037-2
Optimization of pilocarpine loading onto nanoparticles by sorption procedures
T. Harmia (1986)
LHRH agonist and transferring functionalization enhance nanoparticle delivery in a novel bovine ex vivo eye model
UB Kompella (2006)
Size dependency of albumin carrier systems on the in vivo effects of pilocarpine in the rabbit
AK Zimmer (1991)
, Size dependency of albumin carrier systems on the in vivo effects of pilocarpine in the rabbit eye
AK Zimmer (1988)
Ophthalmological bioerodible drug dispensing formulation, U.S
JW Shell (1977)
K,Comparative review on conventional advanced ocular drug delivery
B Boarse Manoj (2012)
10.4103/0250-474X.41454
Albumin Microspheres as an Ocular Delivery System for Pilocarpine Nitrate
S. Rathod (2008)
10.1016/0168-3659(85)90057-4
Ocular therapy with nanoparticulate systems for controlled drug delivery
R. Gurny (1985)
International journal of research in pharmacy and chemistry
S Kataria (2011)
Untersuchung von kolloidalen Depot-Arzneistofftrtigersystemen zur Glaukombehandlung, Dissertation, Fachbereich Biochemie
R W Diepold (1988)
Nanotechnology in ocular drug delivery, drug discovery
SK Sahoo (2008)
Evaluation of nanoparticles as drug delivery systems, Preparation methods, Pharm
J. Kreuter (1983)
Ocular disposition of polyhexylcyanoacrylate nanoparticles and of nanoparticle- bound progesterone
J Kreuter (1985)
Enhancement of the miotic response of rabbits with pilocarpineloaded polybutylcyanoacrylate nanoparticles
T Harmia (1986)
Nanoparticles as drug carriers in ophthalmology.
T. Harmia (1987)
10.1023/A:1018995923348
Pharmacokinetic and Pharmacodynamic Aspects of an Ophthalmic Pilocarpine Nanoparticle-Delivery-System
A. Zimmer (2004)
Recent Trends in Ocular Drug Delivery: A Short Review
Ankit Kumar (2011)
10.1007/978-1-4757-4175-9_11
Nanoparticles and Liposomes in Ophthalmic Drug Delivery
J. Kreuter (1987)
10.1007/s11095-005-4596-x
Chitosan Nanoparticles as New Ocular Drug Delivery Systems: In Vitro Stability, in Vivo Fate, and Cellular Toxicity
A. Campos (2005)
Ocular drug delivery: A Review, IJPSR
S Palani (2010)
International journal of research in pharmacy and chemistry, ijrpc
S Kataria (2011)
Ocular disposition and bioavailability of pilocarpine from piloplex and other sustained release drug delivery systems
J R Robinson
Tolerance studies and pharrnacokinetic evaluation of indomethacin-loaded nanocapsules in rabbit
P Billardon (1992)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar